British drugmaker Shire Plc said on Monday it had received an "approvable letter" from U.S. regulators for SPD465, its experimental treatment for attention deficit hyperactivity disorder (ADHD) in adults.
Source: Reuters
Shire gets approvable letter for adult ADHD drug
May 21, 2007 by
